Scienture Holdings Holds Exclusive U.S. Distribution Rights For Kindeva Drug Subsidiary Summit BioSciences' Rezenopy Nasal Spray, Which Received A U.S. Patent Effective May 12

Benzinga Newsdesk www.benzinga.com Neutral 73.9%

Neg 0% Neu 73.9% Pos 0%

Comments

No comments yet. Be the first!